2025年5月29日 周四
Home > Archive>Volume 32, Issue 3, 2024 >194-202
PDF HTML XML Export Cite reminder
Molecular mechanism of interaction between rheumatoid arthritis and atherosclerosis based on bioinformatics
Author:
Affiliation:

1.Department of Cardiology, Affiliated Hospital of Qingdao University, Qingdao, Shangdong 266000, China;2.Department of Cardiology, Fushun Central Hospital, Fushun, Liaoning 113000, China)

Clc Number:

R5

  • Article
    • | |
  • Metrics
    • |
  • Reference [29]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    Aim To investigate the molecular mechanism of interaction between rheumatoid arthritis (RA) and atherosclerosis (As) based on bioinformatics analysis. Methods The gene expression profiles of As and RA were downloaded from GEO database, differentially expressed genes between RA and As were identified through the test sets, the biological function of common differentially expressed genes was studied by enrichment analysis. Cytoscape software was used to construct the differentially expressed gene protein-protein interaction network and screen the hub genes. Transcriptional regulatory relationship revealed by the TRRUST database predicts transcription factors. Transcription factors were validated by test sets, and hub genes were validated by validation sets and blood samples. Results A total of 198 differentially expressed genes were identified. Functional enrichment analysis showed that differentially expressed genes were mainly concentrated in signaling pathways regulated by cytokines, leukocyte migration, positive regulation of leukocytes, and interaction between cytokines and cytokine receptors. Cytoscape demonstrated the differentially expressed genes and gene clustering modules, obtained the hub genes CCL5, CCR1, CCR2, CCR5, IRF8, ITGAM, ITGB2, LCP2, NCF2 and PTPRC, and the results of validation sets showed that the genes were reliable. qPCR results showed that the expression levels of CCR1 and IRF8 in patients with As combined with RA were significantly higher than those in healthy people. Conclusion The regulatory effect of CCR1 and IRF8 is likely to be the hub factor of RA merging with As.

    Reference
    [1] HANNAWI S M, HANNAWI H, AL SALMI I.Cardiovascular risk in rheumatoid arthritis:literature review.Oman Med J, 1,6(3):e262.
    [2] CARBONE F, BONAVENTURA A, LIBERALE L, et al.Atherosclerosis in rheumatoid arthritis:promoters and opponents.Clin Rev Allergy Immunol, 0,8(1):1-14.
    [3] SEMB A G, IKDAHL E, WIBETOE G, et al.Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis.Nat Rev Rheumatol, 0,6(7):361-379.
    [4] JAGPAL A, NAVARRO-MILLN I.Cardiovascular co-morbidity in patients with rheumatoid arthritis:a narrative review of risk factors, cardiovascular risk assessment and treatment.BMC Rheumatol, 8,2:10.
    [5] SCHMIDT T, MANKAD R.Assessment of cardiac risk in women with autoimmune disease.Curr Cardiol Rep, 2,4(7):775-784.
    [6] REISS A B, SILVERMAN A, KHALFAN M, et al.Accelerated atherosclerosis in rheumatoid arthritis:mechanisms and treatment.Curr Pharm Des, 9,5(9):969-986.
    [7] ARIDA A, LEGAKI A I, KRAVVARITI E, et al.PCSK9/LDLR system and rheumatoid arthritis-related atherosclerosis.Front Cardiovasc Med, 1,8:738764.
    [8] BALDINI C, MORICONI F R, GALIMBERTI S, et al.The JAK-STAT pathway:an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms.Eur Heart J, 1,2(42):4389-4400.
    [9] FULL L E, RUISANCHEZ C, MONACO C.The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus.Arthritis Res Ther, 9,1(2):217.
    [10] KANG S, SONG J.Robust gene selection methods using weighting schemes for microarray data analysis.BMC Bioinformatics, 7,8(1):389.
    [11] BARRETT T, WILHITE S E, LEDOUX P, et al.NCBI GEO:archive for functional genomics data sets-update.Nucleic Acids Res, 3,1:D991-D995.
    [12] WU T Z, HU E Q, XU S B, et al.clusterProfiler 4.0:a universal enrichment tool for interpreting omics data.Innovation (Camb), 1,2(3):100141.
    [13] SZKLARCZYK D, GABLE A L, LYON D, et al.STRING v11:protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.Nucleic Acids Res, 9,7(D1):D607-D613.
    [14] OTASEK D, MORRIS J H, BOUAS J, et al.Cytoscape automation:empowering workflow-based network analysis.Genome Biol, 9,0(1):185.
    [15] WARDE-FARLEY D, DONALDSON S L, COMES O, et al.The GeneMANIA prediction server:biological network integration for gene prioritization and predicting gene function.Nucleic Acids Res, 0,8:W214-W220.
    [16] HAN H, CHO J W, LEE S, et al.TRRUST v2:an expanded reference database of human and mouse transcriptional regulatory interactions.Nucleic Acids Res, 8,6(D1):D380-D386.
    [17] ADAWI M, FIRAS S, BLUM A.Rheumatoid arthritis and atherosclerosis.Isr Med Assoc J, 9,1(7):460-463.
    [18] SCHLOSS M J, SWIRSKI F K, NAHRENDORF M.Modifiable cardiovascular risk, hematopoiesis, and innate immunity.Circ Res, 0,6(9):1242-1259.
    [19] 徐芳芷, 窦琳, 沈涛, 等.免疫细胞在动脉粥样硬化中的代谢重编程现象.中国动脉硬化杂志, 3,1(3):218-4,0.XU F Z, DOU L, SHEN T, et al.Metabolic reprogramming of immune cells in atherosclerosis.Chin J Arterioscler, 3,1(3):218-4,0.
    [20] 何欣, 顾宁.免疫细胞与动脉粥样硬化斑块研究进展.中国动脉硬化杂志, 1,9(7):629-634.HE X, GU N.The research progress between immune cells and atherosclerotic plaques.Chin J Arterioscler, 1,9(7):629-634.
    [21] CUTOLO M, CAMPITIELLO R, GOTELLI E, et al.The role of M1/M2 macrophage polarization in rheumatoid arthritis synovitis.Front Immunol, 2,3:867260.
    [22] JEHLE J, SCHNE B, BAGHERI S, et al.Elevated levels of 2-arachidonoylglycerol promote atherogenesis in ApoE－/－ mice.PLoS One, 8,3(5):e0197751.
    [23] CHOU P H, CHEE A, SHI P, et al.Small molecule antagonist of C-C chemokine receptor 1 (CCR1) reduces disc inflammation in the rabbit model.Spine J, 0,0(12):2025-2036.
    [24] CLMENT M, HADDAD Y, RAFFORT J, et al.Deletion of IRF8 (interferon regulatory factor 8)-dependent dendritic cells abrogates proatherogenic adaptive immunity.Circ Res, 8,2(6):813-820.
    [25] UMAR S, PALASIEWICZ K, VOLIN M V, et al.Metabolic regulation of RA macrophages is distinct from RA fibroblasts and blockade of glycolysis alleviates inflammatory phenotype in both cell types.Cell Mol Life Sci, 1,8(23):7693-7707.
    [26] YAO Z Q, GETTING S J, LOCKE I C.Regulation of TNF-induced osteoclast differentiation.Cells, 1,1(1):132.
    [27] ZAFAR A, PONG NG H, DIAMOND-ZALUSKI R, et al.CITED2 inhibits STAT1-IRF1 signaling and atherogenesis.FASEB J, 1,5(9):e21833.
    [28] CAI D C, LIU H X, WANG J, et al.Balasubramide derivative 3C attenuates atherosclerosis in apolipoprotein E-deficient mice:role of AMPK-STAT1-STING signaling pathway.Aging (Albany NY), 1,3(8):12160-12178.
    [29] LIN Y H, WANG Y H, PENG Y J, et al.Interleukin 26 skews macrophage polarization towards M1 phenotype by activating cJUN and the NF-κB pathway.Cells, 0,9(4):938.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

PEI Jixiang, ZHOU Hongji, AN Yi. Molecular mechanism of interaction between rheumatoid arthritis and atherosclerosis based on bioinformatics[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2024,32(3):194-202.

Copy
Share
Article Metrics
  • Abstract:213
  • PDF: 757
  • HTML: 0
  • Cited by: 0
History
  • Received:June 20,2023
  • Revised:December 12,2023
  • Online: April 07,2024
Article QR Code

You are the 50489 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025